近岸蛋白
(688137)
| 流通市值：10.68亿 | | | 总市值：25.24亿 |
| 流通股本：2969.55万 | | | 总股本：7017.54万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 26,087,054.66 | 153,191,370.39 | 110,706,893.65 | 74,689,152.22 |
| 营业收入 | 26,087,054.66 | 153,191,370.39 | 110,706,893.65 | 74,689,152.22 |
| 二、营业总成本 | 35,231,255.14 | 143,259,290.29 | 102,637,221.09 | 66,628,699.98 |
| 营业成本 | 8,275,316.47 | 37,273,866.81 | 19,469,037.66 | 11,523,297.63 |
| 税金及附加 | 382,921.78 | 849,048.14 | 264,615.17 | 221,279.91 |
| 销售费用 | 11,402,508.31 | 43,578,624.86 | 33,303,697.28 | 21,182,212.45 |
| 管理费用 | 11,806,901.67 | 44,257,603.92 | 33,122,496.78 | 21,458,722.41 |
| 研发费用 | 11,000,774.78 | 44,788,915.39 | 37,204,713.45 | 25,305,398.88 |
| 财务费用 | -7,637,167.87 | -27,488,768.83 | -20,727,339.25 | -13,062,211.3 |
| 其中:利息费用 | 982,526.09 | 3,585,866.48 | 2,705,224.26 | 1,833,430.94 |
| 其中:利息收入 | 8,564,906.56 | 30,479,502.38 | 22,229,110.89 | 13,493,197.8 |
| 加:公允价值变动收益 | -1,804,926.16 | -1,748,049.19 | -2,793,941.11 | -3,128,717.82 |
| 加:投资收益 | 4,569,887.11 | 18,939,889.24 | 16,337,814.07 | 12,585,296.75 |
| 资产处置收益 | - | 145.97 | - | - |
| 资产减值损失(新) | -7,608,392.83 | -33,419,646.99 | -18,506,410.18 | -13,181,461.4 |
| 信用减值损失(新) | -28,696.43 | 1,142,584.27 | 769,453.37 | 572,750.57 |
| 其他收益 | 9,018,682.09 | 11,665,012.87 | 8,203,860.19 | 6,164,053.19 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -4,997,646.7 | 6,512,016.27 | 12,080,448.9 | 11,072,373.53 |
| 加:营业外收入 | 4,900 | 20.59 | 20.59 | 20.57 |
| 减:营业外支出 | 509,653.29 | 289,815.36 | 193,091.85 | 17,114.49 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -5,502,399.99 | 6,222,221.5 | 11,887,377.64 | 11,055,279.61 |
| 减:所得税费用 | -2,871,925.31 | -6,621,351.01 | -3,989,295.05 | -1,305,036.02 |
| 六、净利润 | -2,630,474.68 | 12,843,572.51 | 15,876,672.69 | 12,360,315.63 |
| 持续经营净利润 | -2,630,474.68 | 12,843,572.51 | 15,876,672.69 | 12,360,315.63 |
| 归属于母公司股东的净利润 | -2,630,474.68 | 12,843,572.51 | 15,876,672.69 | 12,360,315.63 |
| (一)基本每股收益 | -0.04 | 0.18 | 0.23 | 0.18 |
| (二)稀释每股收益 | -0.04 | 0.18 | 0.23 | 0.18 |
| 八、其他综合收益 | -17,183.78 | -5,543.93 | -9,635.22 | -11,398.73 |
| 归属于母公司股东的其他综合收益 | -17,183.78 | -5,543.93 | -9,635.22 | -11,398.73 |
| 九、综合收益总额 | -2,647,658.46 | 12,838,028.58 | 15,867,037.47 | 12,348,916.9 |
| 归属于母公司股东的综合收益总额 | -2,647,658.46 | 12,838,028.58 | 15,867,037.47 | 12,348,916.9 |
| 公告日期 | 2024-04-29 | 2024-04-29 | 2023-10-31 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |